Langerhans cell histiocytosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Langerhans cell histiocytosis}} | {{Langerhans cell histiocytosis}} | ||
{{CMG}}; {{AE}} {{HL}} | {{CMG}}; {{AE}} {{HL}} | ||
==Overview== | |||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
===Incidence=== | |||
===Age=== | |||
===Gender=== | |||
===Race=== | |||
==References== | ==References== | ||
Revision as of 15:29, 4 February 2016
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis epidemiology and demographics |
|
FDA on Langerhans cell histiocytosis epidemiology and demographics |
|
on Langerhans cell histiocytosis epidemiology and demographics |
|
Langerhans cell histiocytosis epidemiology and demographics in the news |
|
Blogs on Langerhans cell histiocytosis epidemiology and demographics |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]